Skip to main content
Loading...

Breadcrumb

CEEHRC / Seminars /

Friday, November 25 @ 9am PT / 12pm ET

Register now!

Selin Jessa is a computational biologist finishing her PhD in the lab of Dr. Claudia Kleinman in the Quantitative Life Sciences program at McGill University. She completed her undergraduate training in computer science & biology. Her doctoral work is focused on using data-driven approaches to understand the origins of pediatric brain tumors, by studying relevant regions and cell types in the normal developing brain.

Dr Claudia Kleinman is an Associate Professor in the Department of Human Genetics, Faculty of Medicine, at McGill University, Montreal, Canada. She is a fulltime Investigator at the Lady Davis Institute for Medical Research, an Associate Member of the McGill Centre for Translational Research in Cancer, and a researcher at the Ludmer Centre for Neuroinformatics & Mental Health. Her research exploits genome-wide technologies and data science to understand mechanisms of gene expression. She has an interdisciplinary training that combines molecular biology, computer science, statistics and evolutionary biology, which she applies to the study of pathological transcriptional and RNA processing events, focusing particularly on pediatric brain tumors. She has received awards from the Natural Sciences and Engineering Research Council of Canada (NSERC), Fond de Recherche du Québec – Santé (FRQS), Canadian Institutes of Health Research (CIHR) and currently holds a career award from the Fond de Recherche du Québec – Santé (FRQS). She is the recipient of the Bernard and Francine Dorval Prize, for her work mapping the development of the human brain at the single cell level to define the origins of pediatric brain tumors.

 

 

Upcoming Seminars

Date

Speaker

November 25 @ 9 am PT / 12 noon ET Dr. Claudia Kleinman - McGill University
December 16 @ 9 am PT / 12 noon ET Dr. Jamie Kramer - Dalhousie University

 

Past Seminars

Glioma and Histones

Drs. Cynthia Hawkins and Robert Siddaway

September 23, 2022

TADs and Cancer

Dr. Michael Witcher and Benjamin Lebeau

June 23, 2022

Long Noncoding RNA

Dr. Joel Ross and Shelby Squires

May 27, 2022

Medulloblastoma

Drs. Michael D. Taylor and John Lee

April 22, 2022

Hepatic Cell Fate

Drs. Pamela Hoodless and Bettina Fuglerud

March 25, 2022

Cancer Stem Cells

Drs. Mathieu Lupien and Giacomo Grillo

February 25, 2022

Nucleome Dynamics

Dr. Jacek Majewski and Frank Hu

January 28, 2022

Breast Cancer

Dr. Geneviève Deblois and Marina Fukano

December 17, 2021

Muscle Repair

Drs. F. Jeffrey Dilworth and Kiran Nakka

September 17, 2021

Epigenetic Enhancers

Dr. Michael D. Wilson and Minggao Liang

June 06, 2021

ATXR5

Dr. François Couture and Hossein Davarinejad

April 16, 2021

Microglial Cells

Dr. Annie Ciernia and Jennifer Kim

March 19, 2021

Chromatin

Drs. Michael Hendzel and Hilmar Strickfaden

February 2, 2021

Histone 3

Drs. Nada Jabado and Carol Chen

January 22, 2021

DNA Methylation

Drs. Matthew Lorincz and Julien Richard Albert

November 27, 2020

X-Chromosome Inactivation

Dr. Carolyn Brown and Bradley Balaton

October 23, 2020

Histone Variants in Glioblastoma

Drs. Marco Gallo and Ana Nikolic

September 25, 2020